Real-time funding, M&A, exec moves & hiring — the signals that move deals
More real-time opportunities that match your ICP — every funding, M&A, and exec move the moment it breaks, with the verified contacts to reach out first.
Funding, M&A, exec moves & hiring — every signal Fundz sees, the moment it happens. See who’s in your market, who to reach, and why now.
Vanda Pharmaceuticals Inc.
AI Executive Summary
AI-powered analysis of 8-K filing content
Timothy Williams, Senior Vice President, General Counsel and Secretary of Vanda Pharmaceuticals, resigned effective April 10, 2026. This departure creates a leadership gap in the company's legal and governance functions during a critical period.
Key Takeaways
Timothy Williams resigned as SVP, General Counsel and Secretary with an effective date of April 10, 2026
Williams is departing to pursue other endeavors, indicating a voluntary resignation rather than a termination
2 more takeaways
Related Filings (3)
3 more filings from Vanda Pharmaceuticals Inc. in the last 90 days